Literature DB >> 35838907

The Human LRRK2 Modulates the Age-Dependent Effects of Developmental Methylmercury Exposure in Caenorhabditis elegans.

Tao Ke1, Alexey A Tinkov2,3, Anatoly V Skalny2, Abel Santamaria4, Marcelo Farina5, João B T Rocha6, Aaron B Bowman7, Michael Aschner8.   

Abstract

Methylmercury (MeHg) neurotoxicity exhibits age-dependent effects with a latent and/or persistent neurotoxic effect on aged animals. Individual susceptibility to MeHg neurotoxicity is governed by both exposure duration and genetic factors that can magnify or mitigate the pathologic processes associated with this exposure. We previously showed the G2019S mutation of leucine-rich repeat kinase 2 (LRRK2) modulates the response of worms to high levels of MeHg, mitigating its effect on neuronal morphology in pre-vesicles in cephalic (CEP) dopaminergic neurons. Here we sought to better understand the long-term effects of MeHg exposure at low levels (100-fold lower than that in our previous report) and the modulatory role of the LRRK2 mutation. Worms exposed to MeHg (10 or 50 nM) at the larval stage (L1 stage) were compared at adult stages (young age: day 1 adult; middle age: day 5 adult; old age: day 10 adult) for the swimming speeds in M9 buffer, moving speeds during locomotion on an OP50-seeded plate, and the numbers of CEP dopaminergic pre-vesicles, vesicular structures originating from the dendrites of CEP for exportation of cellular content. In addition, the expression levels of Caenorhabditis elegans homologs of dopamine transporter (dat-1) and tyrosine hydroxylase (cat-2) were also analyzed at these adult stages. Our data showed that swimming speeds were reduced in wild-type worms at the day 10 adult stage at 50 nM MeHg level; yet, reduced swimming speeds were noted in the G2019S LRRK2 transgenic line upon MeHg exposures as low as 10 nM. Compared to locomotor speeds, swimming speeds appear to be more sensitive to the behavioral effects of developmental MeHg exposures, as the locomotor speeds were largely intact and indistinguishable from controls following MeHg exposures. Furthermore, we showed an age-dependent modulation of dat-1 and cat-2 expressions, which could also be modified by the LRRK2 mutation. Although MeHg exposures did not change the number of pre-vesicles, the LRRK2 mutation was associated with increased numbers of pre-vesicles in aged worms. Our data suggest that the latent behavioral effects of MeHg are sensitized by the G2019S LRRK2 mutation, and the underlying mechanism likely involves age-dependent changes in dopaminergic signaling.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Caenorhabditis elegans; Dopaminergic neurons; Leucine-rich repeat kinase 2; Locomotion; Methylmercury; Swimming

Mesh:

Substances:

Year:  2022        PMID: 35838907     DOI: 10.1007/s12640-022-00547-x

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.978


  49 in total

Review 1.  The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?

Authors:  Donato A Di Monte
Journal:  Lancet Neurol       Date:  2003-09       Impact factor: 44.182

Review 2.  Effects of methylmercury on spinal cord afferents and efferents-A review.

Authors:  Alexandra Colón-Rodríguez; Heidi E Hannon; William D Atchison
Journal:  Neurotoxicology       Date:  2016-12-29       Impact factor: 4.294

3.  Age-related and regional differences in dopamine transporter mRNA expression in human midbrain.

Authors:  M J Bannon; C J Whitty
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

4.  Methylmercury poisoning in Iraq.

Authors:  F Bakir; S F Damluji; L Amin-Zaki; M Murtadha; A Khalidi; N Y al-Rawi; S Tikriti; H I Dahahir; T W Clarkson; J C Smith; R A Doherty
Journal:  Science       Date:  1973-07-20       Impact factor: 47.728

5.  Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.

Authors:  L N Clark; Y Wang; E Karlins; L Saito; H Mejia-Santana; J Harris; E D Louis; L J Cote; H Andrews; S Fahn; C Waters; B Ford; S Frucht; R Ottman; K Marder
Journal:  Neurology       Date:  2006-10-18       Impact factor: 9.910

Review 6.  Toxin-induced models of Parkinson's disease.

Authors:  Jordi Bové; Delphine Prou; Céline Perier; Serge Przedborski
Journal:  NeuroRx       Date:  2005-07

7.  Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age.

Authors:  M J Bannon; M S Poosch; Y Xia; D J Goebel; B Cassin; G Kapatos
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

8.  Methylmercury poisoning: long-term clinical, radiological, toxicological, and pathological studies of an affected family.

Authors:  L E Davis; M Kornfeld; H S Mooney; K J Fiedler; K Y Haaland; W W Orrison; E Cernichiari; T W Clarkson
Journal:  Ann Neurol       Date:  1994-06       Impact factor: 10.422

9.  LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease.

Authors:  Ahmed Bouhouche; Houyam Tibar; Rafiqua Ben El Haj; Khalil El Bayad; Rachid Razine; Sanaa Tazrout; Asmae Skalli; Naima Bouslam; Loubna Elouardi; Ali Benomar; Mohammed Yahyaoui; Wafa Regragui
Journal:  Parkinsons Dis       Date:  2017-03-30

Review 10.  Parkinson's Disease and the Environment.

Authors:  Nicole Ball; Wei-Peng Teo; Shaneel Chandra; James Chapman
Journal:  Front Neurol       Date:  2019-03-19       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.